“`html
Shares of Johnson & Johnson (NYSE: JNJ) have surpassed the average analyst 12-month target price of $175.77, currently trading at $176.64 per share. This shift prompts analysts to consider either downgrading due to valuation or adjusting their target prices upward based on new fundamental developments.
There are 22 analysts contributing to JNJ’s average target, with estimates ranging from $155.00 to $193.00, and a standard deviation of $10.169. Current analyst ratings include 10 strong buy, 2 buy, and 13 hold ratings, with an average rating of 2.12 on a scale where 1 is strong buy and 5 is strong sell.
“`
